November 26, 2024

New Member: Welcome in our cluster to Myotwin GmbH

New Member: Welcome in our cluster to Myotwin GmbH
Go back

At Myotwin, the vision is to revolutionize drug development through innovation and compassion. The team is creating a digital twin of the human heart muscle, built from extensive high-content datasets, to enable animal-free drug testing. This groundbreaking platform aims to reshape pharmaceutical research by offering ethical, precise, and effective drug testing methods. By leveraging technology and data-driven insights, myotwin seeks to advance safer treatments while promoting animal welfare.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

High-throughput testing of drugs on mini-tumors reveals vulnerabilities in meningiomas

Meningiomas are the most common brain tumors. Until now, only two methods have generally been considered for treating them: surgery and radiation therapy. A research team in Heidelberg has now developed a potential new approach for effective systemic therapy. Its members from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital (UKHD) tested the effectiveness […]

read more
Development of a method for improved monitoring of the early stages of bone marrow cancer

Development of a method for improved monitoring of the early stages of bone marrow cancer

An international team, including researchers from Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital, has developed the PANGEA-SMM prognostic tool. This tool makes it possible to determine with greater accuracy than before whether a precancerous condition—known as “smoldering multiple myeloma”—is progressing and thus requires treatment. The free online tool for treatment teams is available […]

read more
Strategic Investment in Germany: Roche Opens State-of-the-Art €90 Million Distribution Center in Mannheim

Strategic Investment in Germany: Roche Opens State-of-the-Art €90 Million Distribution Center in Mannheim

Full Text in German below. Strategische Investition in Deutschland: Roche weiht hochmodernes 90-Millionen-Euro-Distributionszentrum in Mannheim ein Mannheim, 23. März 2026 Mit einer Investition von 90 Millionen Euro stärkt Roche den Standort Mannheim als ein zentrales Drehkreuz im globalen Distributionsnetzwerk für Diagnostika des Unternehmens. Das neue Distributionszentrum für Europa umfasst eine Fläche von rund 16.300 Quadratmetern, […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp